The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). Show more
http://www.fool.com/investing/general/2015/12/05/these-3-etfs-jumped-in-november.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/30/last-weeks-top-healthcare-etf.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/22/3-biotech-stocks-to-buy-in-december.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/01/the-top-3-biotech-etfs-on-the-market.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/05/31/improve-your-diversification-strategy-with-these-3.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/high-growth/2015/05/09/a-stock-market-bubble-in-biotech-stocks.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/beginning/2015/04/19/how-to-invest-money-in-biotech.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/etf/2015/03/31/these-3-etfs-are-crushing-the-market-in-2015.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/general/2015/03/23/3-biotech-stocks-to-buy-if-the-sector-crashes.aspx?source=eptadnlnk0000002
State Street Global Advisors (SSGA) announced today that the SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an authorized claimant from a class action settlement related to Human...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.3 | 2.55470398756 | 90.03 | 92.475 | 88.63 | 8270231 | 90.96694386 | SP |
4 | -7.45 | -7.4664261375 | 99.78 | 100.24 | 88.63 | 8203153 | 94.76888254 | SP |
12 | -5.19 | -5.3219852338 | 97.52 | 105.47 | 88.63 | 8385817 | 96.74860957 | SP |
26 | -0.59 | -0.634954799828 | 92.92 | 105.47 | 88.63 | 7953154 | 97.43838339 | SP |
52 | 3.53 | 3.97522522523 | 88.8 | 105.47 | 81.14 | 9258790 | 93.94946514 | SP |
156 | -25.05 | -21.3409439428 | 117.38 | 117.57 | 61.78 | 10065599 | 85.40100913 | SP |
260 | -6.46 | -6.53912339306 | 98.79 | 174.79 | 61.78 | 8462037 | 94.55376964 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.